ATE75480T1 - Gangliosid-derivate. - Google Patents

Gangliosid-derivate.

Info

Publication number
ATE75480T1
ATE75480T1 AT84108621T AT84108621T ATE75480T1 AT E75480 T1 ATE75480 T1 AT E75480T1 AT 84108621 T AT84108621 T AT 84108621T AT 84108621 T AT84108621 T AT 84108621T AT E75480 T1 ATE75480 T1 AT E75480T1
Authority
AT
Austria
Prior art keywords
ganglioside
sub
mono
novel
sialo
Prior art date
Application number
AT84108621T
Other languages
English (en)
Inventor
Ezio Tubaro
Giovanni Cavallo
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE75480T1 publication Critical patent/ATE75480T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT84108621T 1983-07-21 1984-07-20 Gangliosid-derivate. ATE75480T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48724/83A IT1168205B (it) 1983-07-21 1983-07-21 Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
EP84108621A EP0136438B1 (de) 1983-07-21 1984-07-20 Gangliosid-Derivate

Publications (1)

Publication Number Publication Date
ATE75480T1 true ATE75480T1 (de) 1992-05-15

Family

ID=11268264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84108621T ATE75480T1 (de) 1983-07-21 1984-07-20 Gangliosid-derivate.

Country Status (9)

Country Link
US (2) US4728641A (de)
EP (1) EP0136438B1 (de)
JP (1) JPS6084296A (de)
AT (1) ATE75480T1 (de)
DE (1) DE3485680D1 (de)
DK (1) DK166828B1 (de)
ES (1) ES534494A0 (de)
HU (1) HU198091B (de)
IT (1) IT1168205B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660557A5 (fr) * 1984-10-26 1987-05-15 Nestle Sa Composition anti-bacterienne et procede de preparation de ses constituants actifs.
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0653764B2 (ja) * 1985-07-31 1994-07-20 三井東圧化学株式会社 モノシアロガングリオシドの製造法
ATE94395T1 (de) * 1986-05-09 1993-10-15 Pulverer Gerhard Verwendung von spezifischen monosacchariden zur herstellung eines arzneimittels zur verhinderung von metastasen maligner tumore.
IT1208751B (it) * 1986-06-30 1989-07-10 Fidia Farmaceutici Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali
EP0508493A1 (de) * 1986-08-06 1992-10-14 Mect Corporation Gangliosidderivate und Verfahren zur Herstellung davon
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
WO1991008747A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
WO1991008748A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
DE4204907A1 (de) * 1992-02-14 1993-08-19 Reutter Werner Neuartige glykokonjugate mit n-substituierten neuraminsaeuren als mittel zur stimulierung des immunsystems
TW261533B (de) * 1992-07-16 1995-11-01 Kirin Brewery
AU683026B2 (en) * 1992-10-22 1997-10-30 Kirin Pharma Kabushiki Kaisha Novel shingoglycolipid and use thereof
CA2160566C (en) * 1993-04-15 2004-07-13 Tatsuo Higa Novel sphingoglycolipids and uses thereof
DE19602108A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
DE19643585A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sphingolipide
AU2001285359A1 (en) * 2000-09-01 2002-03-13 Neuronyx, Inc. Novel synthetic gangliosides
US20020072502A1 (en) * 2000-09-01 2002-06-13 Neuronyx, Inc. Novel synthetic gangliosides
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
EP1367395A1 (de) * 2002-05-02 2003-12-03 B.R.A.H.M.S Aktiengesellschaft Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
EP1358910A1 (de) * 2002-05-02 2003-11-05 B.R.A.H.M.S Aktiengesellschaft Verfahren und Mittel zur Prävention, Hemmung und Therapie von Krebserkrankungen
US9969977B2 (en) * 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
NZ542148A (en) 2003-03-06 2008-05-30 Neose Technologies Inc Methods and compositions for the enzymatic synthesis of gangliosides
JP4965063B2 (ja) * 2004-05-07 2012-07-04 雪印メグミルク株式会社 口腔内細菌叢改善剤、抗菌剤及び生育促進剤。
EP1794507B1 (de) 2004-09-23 2013-05-01 CSR Building Products Limited Hybridventilator
WO2008156728A1 (en) * 2007-06-15 2008-12-24 Neuronyx, Inc. Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro
WO2009123877A1 (en) * 2008-03-21 2009-10-08 Braincells, Inc. A method of treating a nervous system disorder by modulation of neurogenesis with mcc-257
DE102010024041A1 (de) * 2010-05-16 2013-04-04 Alfred Kroll Symtomfreiheit der Atemwege

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT295036B (de) * 1968-11-29 1971-12-27 Leikola Erkki E Verfahren zur Herstellung von neuen Produkten tierischen Ursprungs
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
JPS57500609A (de) * 1980-05-09 1982-04-08
CH658458A5 (fr) * 1981-12-17 1986-11-14 Lucchini Lab Sa Procede pour l'obtention du lacto-n-norhexaosyl ceramide.

Also Published As

Publication number Publication date
DK166828B1 (da) 1993-07-19
HU198091B (en) 1989-07-28
DE3485680D1 (de) 1992-06-04
EP0136438A3 (en) 1987-05-13
DK356984D0 (da) 1984-07-20
HUT35690A (en) 1985-07-29
ES8603191A1 (es) 1985-12-01
DK356984A (da) 1985-01-22
IT8348724A0 (it) 1983-07-21
JPS6084296A (ja) 1985-05-13
ES534494A0 (es) 1985-12-01
IT8348724A1 (it) 1985-01-21
EP0136438A2 (de) 1985-04-10
EP0136438B1 (de) 1992-04-29
IT1168205B (it) 1987-05-20
US4728641A (en) 1988-03-01
US4831021A (en) 1989-05-16

Similar Documents

Publication Publication Date Title
DE3485680D1 (de) Gangliosid-derivate.
AU549885B2 (en) Heparin degradation via ascorbic acid, cupric acetate and hydrogen peroxide
IT1148790B (it) Soluzioni medicinali stabili, applicabili per via parenterale dotate di azione anti-infiammatoria
AU573321B2 (en) Process for solubilizing active principles and pharmaceuticalcompositions thus obtained
IE36724B1 (en) Imidazole derivatives
JPS536412A (en) Preparation of n-containing polysaccharides
IE37913B1 (en) Salt of s-adenosyl-l-methionine
EP0293826A3 (de) Therapeutische und prophylaktische Gabe von sulfatierten Polysacchariden gegen AIDS
FI931274A0 (fi) Menetelmä puhdistettujen glykolipidien valmistamiseksi käyttäen membraanierotusmenetelmää
IE35177L (en) Piperazinyl-uracil derivatives.
AU6076886A (en) Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
ATE27914T1 (de) Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.
CA924712A (en) PROCESS FOR THE PRODUCTION OF 9-(.beta.-D-ARABINOFURANOSYL)-ADENINE, 5'-PHOSPHATE AND SALTS THEREOF
ES8407064A1 (es) "procedimiento para la preparacion de compuestos de la serie de los glicolipidos regeneradores de celulas y tejidos"
NO923581L (no) Sykliske substituerte imidazolylpropensyrederivater
ES341109A1 (es) Metodo para la preparacion de nuevas sales basicas de adi- cion de acido ribonucleico.
DK131324B (da) Fremgangsmåde til fremstilling af et lægemiddel i form af en klar, steril vandig opløsning.
BG47648A3 (en) Method for preparing of triazolyl quanolinic compounds
MY130107A (en) Piperidylmethyl-substituted chroman derivatives
NO175802C (no) Fremgangsmåte for fremstilling av en lagringsstabil antracyklinglycosidopplösning
GB840206A (en) A process for the treatment of artificial sponges of regenerated cellulose, to prevent attack by bacteria and fungi and the sponges thus treated
Watanabe Sinanomycin (Netropsin) Produced By Streptomyces Sp. No. 7618 Studies on the Antibiotic Substances From Actinomyces, XXXVII
FI50125C (fi) Menetelmä terapeuttisesti käytettävien /1,1-ditienyyli-1-hydroksi-prop yyli-(3)/-/1-fenyyli-alkyyli/-amiinien ja näiden suolojen valmistamise ksi.
CN110882263A (zh) 礁膜寡二糖与礁膜寡二糖衍生物在抗乳腺癌中的应用
DE2835878A1 (de) Oligosaccharid mit durch glucocorticoide bedingte enzyminduktion verstaerkender wirkung, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel